Company Filing History:
Years Active: 1984-1990
Title: Charles V Magatti: A Collaborative Inventor and Researcher
Introduction:
In the fascinating realm of innovations and patents, there are pioneers whose contributions leave a lasting impact on various industries. One such figure is Charles V Magatti, hailing from Verona, NJ. Magatti has established himself as a prolific inventor and researcher, with an impressive portfolio of patents and a rich career history. In this article, we delve into Magatti's latest patents, career highlights, and his collaborations with other industry experts.
Latest Patents:
Magatti has demonstrated his expertise in pharmaceuticals with his two latest patents. The first patent, titled "Phosphodiesterase inhibitors having an optionally substituted purine," unveils antihypertensive phosphodiesterase inhibitors consisting of a purine derivative portion and a benzo- or cyclopenta-furan derivative portion. This innovation holds immense potential in the field of hypertension treatment.
The second patent, titled "Antiglaucoma compositions and methods," focuses on ophthalmological pharmaceutical compositions. These compositions utilize (benzothiadiazine, benzamide, and benzenesulfonyl)phenyl-substituted carboxyalkyl dipeptide compounds with the aim of reducing intraocular pressure. This patent provides a promising avenue for the treatment of glaucoma.
Career Highlights:
Magatti has proven his prowess in the world of patents, boasting an impressive total of seven patents to date. His dedication to pushing the boundaries of innovation is commendable, as evidenced by the breadth of his contributions. Magatti is associated with the renowned Schering Corporation, a company renowned for its advancements in the pharmaceutical industry. Through his work at Schering Corporation, Magatti has made significant strides in the field, cementing his reputation as a valuable asset to the company.
Collaborations:
Innovation often thrives on collaboration, and Magatti exemplifies this through his fruitful partnerships with other inventors and researchers. Notably, Magatti has worked closely with Ronald J Doll and Bernard R Neustadt on various projects. Such collaborations foster an environment of shared knowledge and expertise, leading to groundbreaking advancements that shape industries.
Conclusion:
Charles V Magatti has showcased his exemplary skills as an inventor and researcher through his prolific career and noteworthy contributions. His latest patents in the field of antihypertensive phosphodiesterase inhibitors and antiglaucoma compositions highlight his dedication to improving medical treatments. Collaborations with fellow experts further emphasize Magatti's commitment to pushing the boundaries of innovation. As the world continues to seek novel solutions, inventors like Magatti play a vital role in shaping a future where breakthroughs are aplenty.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.